For early screening of cancer in general risk, asymptomatic individuals, the article makes a large table. Those closely related to the female breast and reproductive system are translated below. For breast cancer screening should begin at ≥20 years of age. Self-examination: It is acceptable to do self-examination or not. Women should be aware of the benefits and drawbacks of self-examination. With or without self-examination, timely reporting of any new breast symptoms should be emphasized. Women who choose to self-screen should be coached and their skills evaluated during regular physical examinations. Clinical checkups: For women in their 20s and 30s, a clinical checkup is recommended as part of a normal physical examination, at least every 3 years. Women who are asymptomatic and ≥40 years of age should continue to have a clinical examination, preferably once a year. Mammography: preferably once a year starting at age 40 years. For cervical cancer screening can be performed between the ages of 21-65 years. Cervical cancer screening should begin at age 21. For women between the ages of 21-29, a traditional Pap smear or liquid-based cytology should be performed every 3 years. For women aged 30-65 years, Pap smears combined with HPV should ideally be performed every 5 years or every 3 years (acceptable). For women >65 years of age who have had ≥3 consecutive negative Pap smears or ≥2 consecutive Pap smears + HPV in the past 10 years (the most recent test should have been performed within 5 years) or who have had a total hysterectomy, screening should be discontinued if there is no cervical preservation, no CIN2 or more severe lesions in the past 20 years, or no history of cervical cancer. Women of any age should not undergo annual screening by any method. For women who develop CIN2 or more severe disease between the ages of 30-65, routine follow-up should continue for at least 20 years (even if follow-up is beyond age 65). Endometrial cancer should be taken seriously at the time of menopause. Women at average risk at menopause should be aware of the risks and symptoms of endometrial cancer. Women are strongly encouraged to report any symptoms of bleeding to their physician. Screening for endometrial cancer should begin at age 35 for women who are carriers of the genetic variant of Lynch syndrome, or are likely to be carriers of the variant (e.g., carriers of the variant in the family), or have a dominantly inherited member of the family with rectal cancer who has not been screened for genetics herself. Histologic screening by endometrial biopsy remains the gold standard. For ovarian cancer, routine screening is generally not recommended. CA125 combined with transvaginal ultrasound does not reduce mortality from ovarian cancer.